Debra L. Richardson, MD, FACS, FACOG, discusses the impact of selinexor’s mechanism of action on the agent’s clinical efficacy in patients with TP53 wild-type advanced or recurrent endometrial cancer.
OKLAHOMA CITY — An innovative new fertility preservation option offered at OU Health is giving new hope to patients who face medical treatments that are likely to impair their ability
Business supports Stephenson Cancer Center | The Journal Record journalrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalrecord.com Daily Mail and Mail on Sunday newspapers.
OU Health researchers receive millions in grants to study endometrial cancer kosu.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kosu.org Daily Mail and Mail on Sunday newspapers.
OU Health researchers receive millions in grants to study endometrial cancer kgou.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kgou.org Daily Mail and Mail on Sunday newspapers.